Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Sands, Bruce E., Peyrin-Biroulet, Laurent, Loftus, Edward V., Danese, Silvio, Colombel, Jean-Frederic, Törüner, Murat, Jonaitis, Laimas, Abhyankar, Brihad, Rogers, Raquel, Chen, Jingjing, Lirio, Richard A., Bornstein, Jeffrey D., VARSITY, Study Group, Altorjay, István, Molnár, Tamás: Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
NEW ENGLAND JOURNAL OF MEDICINE, 381 (13). pp. 1215-1226. ISSN 0028-4793 (2019)

[img]
Preview
Text
30999815_Sandsetal.VedolizumabvsadalimumabformoderatetosevereUC.pdf - Published Version

Download (383kB) | Preview
[img]
Preview
Text
30999815_melléklet.pdf - Published Version

Download (2MB) | Preview
Item Type: Article
Journal or Publication Title: NEW ENGLAND JOURNAL OF MEDICINE
Date: 2019
Volume: 381
Number: 13
Page Range: pp. 1215-1226
ISSN: 0028-4793
Faculty: Not Specified
Institution: Szegedi Tudományegyetem
MTMT id: 30999815
DOI id: https://doi.org/10.1056/NEJMoa1905725
Date Deposited: 2020. Aug. 29. 13:43
Last Modified: 2020. Aug. 29. 13:43
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/19396
Web of Science® Times Cited: 74 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year